Literature DB >> 14521993

Learning deficits in forebrain-restricted brain-derived neurotrophic factor mutant mice.

J A Gorski1, S A Balogh, J M Wehner, K R Jones.   

Abstract

Brain-derived neurotrophic factor (BDNF) participates in synaptic plasticity and the adaptive changes in the strength of communication between neurons thought to underlie aspects of behavioral adaptation. By selectively deleting BDNF from the forebrain of mice using the Cre site-specific DNA recombinase, we were able to study the requirements for BDNF in behaviors such as learning and anxiety. Early-onset forebrain-restricted BDNF mutant mice (Emx-BDNF(KO)) that develop in the absence of BDNF in the dorsal cortex, hippocampus, and parts of the ventral cortex and amygdala failed to learn the Morris Water Maze task, a hippocampal-dependent visuo-spatial learning task. Freezing during all phases of cued-contextual fear conditioning, a behavioral task designed to study hippocampal-dependent associative learning, was enhanced. These mice learned a brightness discrimination task well but were impaired in a more difficult pattern discrimination task. Emx-BDNF(KO) mice did not exhibit altered sensory processing and gating, as measured by the acoustic startle response or prepulse inhibition of the startle response. Although they were less active in an open-field arena, they did not show alterations in anxiety, as measured in the elevated-plus maze, black-white chamber or mirrored chamber tasks. Combined, these data indicate that although an absence of forebrain BDNF does not disrupt acoustic sensory processing or alter baseline anxiety, specific forms of learning are severely impaired.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14521993     DOI: 10.1016/s0306-4522(03)00426-3

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  95 in total

1.  NDRG4 protein-deficient mice exhibit spatial learning deficits and vulnerabilities to cerebral ischemia.

Authors:  Hitomi Yamamoto; Koichi Kokame; Tomohiko Okuda; Yukako Nakajo; Hiroji Yanamoto; Toshiyuki Miyata
Journal:  J Biol Chem       Date:  2011-06-02       Impact factor: 5.157

2.  Phosphoinositide 3-kinase enhancer regulates neuronal dendritogenesis and survival in neocortex.

Authors:  Chi Bun Chan; Xia Liu; Sompol Pradoldej; Chunhai Hao; Jie An; Manuel Yepes; Hongbo R Luo; Keqiang Ye
Journal:  J Neurosci       Date:  2011-06-01       Impact factor: 6.167

Review 3.  Brain-derived neurotrophic factor and neuropsychiatric disorders.

Authors:  Anita E Autry; Lisa M Monteggia
Journal:  Pharmacol Rev       Date:  2012-03-08       Impact factor: 25.468

4.  Bone morphogenetic protein signaling in the developing telencephalon controls formation of the hippocampal dentate gyrus and modifies fear-related behavior.

Authors:  Giuliana Caronia; Jennifer Wilcoxon; Polina Feldman; Elizabeth A Grove
Journal:  J Neurosci       Date:  2010-05-05       Impact factor: 6.167

5.  Regulation of brain-derived neurotrophic factor expression in neurons.

Authors:  Fei Zheng; Xianju Zhou; Changjong Moon; Hongbing Wang
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2012-12-26

6.  Selective loss of brain-derived neurotrophic factor in the dentate gyrus attenuates antidepressant efficacy.

Authors:  Megumi Adachi; Michel Barrot; Anita E Autry; David Theobald; Lisa M Monteggia
Journal:  Biol Psychiatry       Date:  2007-11-05       Impact factor: 13.382

7.  Epithelial-derived brain-derived neurotrophic factor is required for gustatory neuron targeting during a critical developmental period.

Authors:  Liqun Ma; Grace F Lopez; Robin F Krimm
Journal:  J Neurosci       Date:  2009-03-18       Impact factor: 6.167

8.  The neurotrophin-inducible gene Vgf regulates hippocampal function and behavior through a brain-derived neurotrophic factor-dependent mechanism.

Authors:  Ozlem Bozdagi; Erin Rich; Sophie Tronel; Masato Sadahiro; Kamara Patterson; Matthew L Shapiro; Cristina M Alberini; George W Huntley; Stephen R J Salton
Journal:  J Neurosci       Date:  2008-09-24       Impact factor: 6.167

Review 9.  Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects.

Authors:  Maarten van den Buuse
Journal:  Schizophr Bull       Date:  2009-11-09       Impact factor: 9.306

10.  Restricting dopaminergic signaling to either dorsolateral or medial striatum facilitates cognition.

Authors:  Martin Darvas; Richard D Palmiter
Journal:  J Neurosci       Date:  2010-01-20       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.